BioPorto A/S Appoints President and CEO of BioPorto Inc. [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
COPENHAGEN, DENMARK and BOSTON, MA, USA, May 7, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), announced today the appointment of Jeffrey N. Haas as new President and Chief Executive Officer of BioPorto Inc. (US), the fully owned subsidiary of BioPorto, and member of the Group's Executive Leadership team. Leading BioPorto's US activities, Jeffrey N. Haas will be responsible for the commercial introduction of the FDA cleared ProNephro AKI™ NGAL for pediatric and young adult clinical use, and lead activities aimed to build ProNephro AKI NGAL awareness, product knowledge, organization and partnerships to ensure strong commercial traction and continuous expansion of the use of the test including expanded indications for use in adult patients. Jeffrey N. Haas joins BioPorto from Abbott Laboratories (US), where he from 2017 served as President of Rapid Dia
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott (ABT) Down 0.4% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]Yahoo! Finance
- Polycystic Ovary Syndrome (PCOS) Treatment Global Strategic Research Report 2024-2030: North America and Europe Dominates, Asia-Pacific to Exhibit Fastest Growth [Yahoo! Finance]Yahoo! Finance
- Global Dietary Supplements Market is Anticipated to Reach USD 380.12 Billion at a CAGR of 8.8% CAGR by 2032 - Report by Polaris Market Research (PMR) [Yahoo! Finance]Yahoo! Finance
- Saudi Arabia Baby Food Market Analysis 2017-2023 and Forecast 2024-2029: Nestle, Abbott Laboratories, and Danone Dominated in 2023 [Yahoo! Finance]Yahoo! Finance
- Global Digital Patient Monitoring Devices Market Set to Surge to US$ 715.9 Billion by 2032: Analysis by Monitoring Type, Product, End User, and Region [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 5/14/24 - Form 4
- 5/10/24 - Form 144
- 5/8/24 - Form 4
- ABT's page on the SEC website